Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

342
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
342
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Cancer Vaccines01:30

Cancer Vaccines

496
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
496
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequence-Defined Short Peptide-Derived Coacervate Vesicles for Targeted Therapeutics.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A Convergent Strategy for Factor Xa Inhibition: Synthesis, Bioinformatics, and Biological Analysis of 3,5-Disubstituted Isoxazoles.

Archiv der Pharmazie·2026
Same author

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

BioMed research international·2026
Same author

Supramolecular Integration of 18-Crown-6 and an N-Capped Short Peptide Enables Multivalent Recognition and Modulation of Amyloid-β Proteotoxicity.

Journal of the American Chemical Society·2026
Same author

State-of-the-Art Review on Probiotics, Synbiotics, and Microbial Metabolites: Molecular Mechanisms Shaping Host Immunity, Metabolic Health, and Chronic Disease Prevention.

Molecular nutrition & food research·2026
Same author

Thiophene-Engineered Lipid II Recognition Enables Potent Membranolytic Eradication of MRSA.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Video

Updated: Aug 30, 2025

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.1K

Vaccine for Diabetes-Where Do We Stand?

Dinesh Kumar Chellappan1, Richie R Bhandare2,3, Afzal B Shaik4

  • 1Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.

International Journal of Molecular Sciences
|August 26, 2022
PubMed
Summary

This review explores diabetes vaccine clinical trials. It examines immunomodulatory agents and their potential to prevent diabetes by targeting autoimmune responses, offering hope for future treatments.

Keywords:
GLPclinical trialsdiabetesinsulinvaccines

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

Related Experiment Videos

Last Updated: Aug 30, 2025

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.1K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

Area of Science:

  • Endocrinology
  • Immunology
  • Vaccinology

Background:

  • Diabetes mellitus is a growing global health concern, significantly impacting morbidity and mortality across age groups.
  • Autoimmune responses are increasingly understood as a key factor in diabetes development.
  • The potential of immunomodulatory agents and vaccines for diabetes prevention is under investigation.

Purpose of the Study:

  • To review ongoing clinical trial studies for prototype diabetes vaccines.
  • To assess the progress and outcomes of diabetes vaccine development.
  • To understand the mechanisms of action for potential diabetes vaccines.

Main Methods:

  • Literature review of current clinical trials for diabetes vaccines.
  • Analysis of studies focusing on immunomodulatory agents and their effects on autoimmune responses in diabetes.
  • Examination of vaccine mechanisms, including T cell modulation and immune cell interaction inhibition.

Main Results:

  • Most diabetes vaccines have been tested in animal models; limited human trials exist.
  • Some human trials have yielded positive outcomes, indicating vaccine potential.
  • The review synthesizes data from various clinical studies on diabetes vaccine development.

Conclusions:

  • Diabetes vaccine development is a promising area for preventing the disease.
  • Further clinical trials are necessary to establish efficacy and safety in humans.
  • Immunomodulatory strategies hold potential for future diabetes prevention therapies.